Global Preterm Birth Prevention and Management Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Preterm Birth Prevention and Management Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Preterm Birth Prevention and Management Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Progesterone Therapy
  • 1.4.3 Corticosteroid Therapy
  • 1.4.4 Tocolytics Therapy
  • 1.4.5 Antihypertensive Therapy
  • 1.4.6 Magnesium Sulfate Therapy
  • 1.4.7 Other
• 1.5 Market by Application
  • 1.5.1 Global Preterm Birth Prevention and Management Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Drugs Stores
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Preterm Birth Prevention and Management Market Perspective (2015-2026)
• 2.2 Preterm Birth Prevention and Management Growth Trends by Regions
  • 2.2.1 Preterm Birth Prevention and Management Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Preterm Birth Prevention and Management Historic Market Share by Regions (2015-2020)
  • 2.2.3 Preterm Birth Prevention and Management Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Preterm Birth Prevention and Management Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Preterm Birth Prevention and Management Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Preterm Birth Prevention and Management Players by Market Size
  • 3.1.1 Global Top Preterm Birth Prevention and Management Players by Revenue (2015-2020)
  • 3.1.2 Global Preterm Birth Prevention and Management Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Preterm Birth Prevention and Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Preterm Birth Prevention and Management Market Concentration Ratio
  • 3.2.1 Global Preterm Birth Prevention and Management Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Preterm Birth Prevention and Management Revenue in 2019
• 3.3 Preterm Birth Prevention and Management Key Players Head office and Area Served
• 3.4 Key Players Preterm Birth Prevention and Management Product Solution and Service
• 3.5 Date of Enter into Preterm Birth Prevention and Management Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Preterm Birth Prevention and Management Historic Market Size by Type (2015-2020)
• 4.2 Global Preterm Birth Prevention and Management Forecasted Market Size by Type (2021-2026)

5 Preterm Birth Prevention and Management Breakdown Data by Application (2015-2026)

• 5.1 Global Preterm Birth Prevention and Management Market Size by Application (2015-2020)
• 5.2 Global Preterm Birth Prevention and Management Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Preterm Birth Prevention and Management Market Size (2015-2020)
• 6.2 Preterm Birth Prevention and Management Key Players in North America (2019-2020)
• 6.3 North America Preterm Birth Prevention and Management Market Size by Type (2015-2020)
• 6.4 North America Preterm Birth Prevention and Management Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Preterm Birth Prevention and Management Market Size (2015-2020)
• 7.2 Preterm Birth Prevention and Management Key Players in Europe (2019-2020)
• 7.3 Europe Preterm Birth Prevention and Management Market Size by Type (2015-2020)
• 7.4 Europe Preterm Birth Prevention and Management Market Size by Application (2015-2020)

8 China

• 8.1 China Preterm Birth Prevention and Management Market Size (2015-2020)
• 8.2 Preterm Birth Prevention and Management Key Players in China (2019-2020)
• 8.3 China Preterm Birth Prevention and Management Market Size by Type (2015-2020)
• 8.4 China Preterm Birth Prevention and Management Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Preterm Birth Prevention and Management Market Size (2015-2020)
• 9.2 Preterm Birth Prevention and Management Key Players in Japan (2019-2020)
• 9.3 Japan Preterm Birth Prevention and Management Market Size by Type (2015-2020)
• 9.4 Japan Preterm Birth Prevention and Management Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Preterm Birth Prevention and Management Market Size (2015-2020)
• 10.2 Preterm Birth Prevention and Management Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Preterm Birth Prevention and Management Market Size by Type (2015-2020)
• 10.4 Southeast Asia Preterm Birth Prevention and Management Market Size by Application (2015-2020)

11 India

• 11.1 India Preterm Birth Prevention and Management Market Size (2015-2020)
• 11.2 Preterm Birth Prevention and Management Key Players in India (2019-2020)
• 11.3 India Preterm Birth Prevention and Management Market Size by Type (2015-2020)
• 11.4 India Preterm Birth Prevention and Management Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Preterm Birth Prevention and Management Market Size (2015-2020)
• 12.2 Preterm Birth Prevention and Management Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Preterm Birth Prevention and Management Market Size by Type (2015-2020)
• 12.4 Central & South America Preterm Birth Prevention and Management Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 AMAG Pharmaceuticals
  • 13.1.1 AMAG Pharmaceuticals Company Details
  • 13.1.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
  • 13.1.3 AMAG Pharmaceuticals Preterm Birth Prevention and Management Introduction
  • 13.1.4 AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Management Business (2015-2020))
  • 13.1.5 AMAG Pharmaceuticals Recent Development
• 13.2 Ferring Pharmaceutical
  • 13.2.1 Ferring Pharmaceutical Company Details
  • 13.2.2 Ferring Pharmaceutical Business Overview and Its Total Revenue
  • 13.2.3 Ferring Pharmaceutical Preterm Birth Prevention and Management Introduction
  • 13.2.4 Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.2.5 Ferring Pharmaceutical Recent Development
• 13.3 Teva
  • 13.3.1 Teva Company Details
  • 13.3.2 Teva Business Overview and Its Total Revenue
  • 13.3.3 Teva Preterm Birth Prevention and Management Introduction
  • 13.3.4 Teva Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.3.5 Teva Recent Development
• 13.4 Allergan
  • 13.4.1 Allergan Company Details
  • 13.4.2 Allergan Business Overview and Its Total Revenue
  • 13.4.3 Allergan Preterm Birth Prevention and Management Introduction
  • 13.4.4 Allergan Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.4.5 Allergan Recent Development
• 13.5 AbbVie
  • 13.5.1 AbbVie Company Details
  • 13.5.2 AbbVie Business Overview and Its Total Revenue
  • 13.5.3 AbbVie Preterm Birth Prevention and Management Introduction
  • 13.5.4 AbbVie Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.5.5 AbbVie Recent Development
• 13.6 Aurobindo Pharma
  • 13.6.1 Aurobindo Pharma Company Details
  • 13.6.2 Aurobindo Pharma Business Overview and Its Total Revenue
  • 13.6.3 Aurobindo Pharma Preterm Birth Prevention and Management Introduction
  • 13.6.4 Aurobindo Pharma Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.6.5 Aurobindo Pharma Recent Development
• 13.7 Bayer
  • 13.7.1 Bayer Company Details
  • 13.7.2 Bayer Business Overview and Its Total Revenue
  • 13.7.3 Bayer Preterm Birth Prevention and Management Introduction
  • 13.7.4 Bayer Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.7.5 Bayer Recent Development
• 13.8 Mylan
  • 13.8.1 Mylan Company Details
  • 13.8.2 Mylan Business Overview and Its Total Revenue
  • 13.8.3 Mylan Preterm Birth Prevention and Management Introduction
  • 13.8.4 Mylan Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.8.5 Mylan Recent Development
• 13.9 Pfizer
  • 13.9.1 Pfizer Company Details
  • 13.9.2 Pfizer Business Overview and Its Total Revenue
  • 13.9.3 Pfizer Preterm Birth Prevention and Management Introduction
  • 13.9.4 Pfizer Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.9.5 Pfizer Recent Development
• 13.10 Merck & Co
  • 13.10.1 Merck & Co Company Details
  • 13.10.2 Merck & Co Business Overview and Its Total Revenue
  • 13.10.3 Merck & Co Preterm Birth Prevention and Management Introduction
  • 13.10.4 Merck & Co Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 13.10.5 Merck & Co Recent Development
• 13.11 Novartis
  • 10.11.1 Novartis Company Details
  • 10.11.2 Novartis Business Overview and Its Total Revenue
  • 10.11.3 Novartis Preterm Birth Prevention and Management Introduction
  • 10.11.4 Novartis Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 10.11.5 Novartis Recent Development
• 13.12 Sanofi
  • 10.12.1 Sanofi Company Details
  • 10.12.2 Sanofi Business Overview and Its Total Revenue
  • 10.12.3 Sanofi Preterm Birth Prevention and Management Introduction
  • 10.12.4 Sanofi Revenue in Preterm Birth Prevention and Management Business (2015-2020)
  • 10.12.5 Sanofi Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer